H2A2B_HUMAN - dbPTM
H2A2B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H2A2B_HUMAN
UniProt AC Q8IUE6
Protein Name Histone H2A type 2-B
Gene Name HIST2H2AB
Organism Homo sapiens (Human).
Sequence Length 130
Subcellular Localization Nucleus. Chromosome.
Protein Description Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling..
Protein Sequence MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTESHKPGKNK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSGRGKQGG
------CCCCCCCCH
36.8815823041
2Acetylation------MSGRGKQGG
------CCCCCCCCH
36.8815823041
4Citrullination----MSGRGKQGGKA
----CCCCCCCCHHH
41.66-
4Citrullination----MSGRGKQGGKA
----CCCCCCCCHHH
41.6615823041
4Methylation----MSGRGKQGGKA
----CCCCCCCCHHH
41.66-
6Methylation--MSGRGKQGGKARA
--CCCCCCCCHHHHH
44.3920612053
6Acetylation--MSGRGKQGGKARA
--CCCCCCCCHHHHH
44.3920612053
6Other--MSGRGKQGGKARA
--CCCCCCCCHHHHH
44.3924681537
10SuccinylationGRGKQGGKARAKAKS
CCCCCCHHHHHHHHH
41.3422389435
10OtherGRGKQGGKARAKAKS
CCCCCCHHHHHHHHH
41.3427105115
10LactoylationGRGKQGGKARAKAKS
CCCCCCHHHHHHHHH
41.34-
10AcetylationGRGKQGGKARAKAKS
CCCCCCHHHHHHHHH
41.3420612049
14OtherQGGKARAKAKSRSSR
CCHHHHHHHHHHHHC
51.2827105115
14UbiquitinationQGGKARAKAKSRSSR
CCHHHHHHHHHHHHC
51.2822980979
14AcetylationQGGKARAKAKSRSSR
CCHHHHHHHHHHHHC
51.28-
16UbiquitinationGKARAKAKSRSSRAG
HHHHHHHHHHHHCCC
45.7722980979
17PhosphorylationKARAKAKSRSSRAGL
HHHHHHHHHHHCCCC
42.1023882029
19PhosphorylationRAKAKSRSSRAGLQF
HHHHHHHHHCCCCCC
31.1330622161
20PhosphorylationAKAKSRSSRAGLQFP
HHHHHHHHCCCCCCC
25.6627966365
21MethylationKAKSRSSRAGLQFPV
HHHHHHHCCCCCCCH
33.64-
30MethylationGLQFPVGRVHRLLRK
CCCCCHHHHHHHHHC
22.69-
37N6-crotonyl-L-lysineRVHRLLRKGNYAERV
HHHHHHHCCCHHHHC
52.02-
37UbiquitinationRVHRLLRKGNYAERV
HHHHHHHCCCHHHHC
52.0227667366
37CrotonylationRVHRLLRKGNYAERV
HHHHHHHCCCHHHHC
52.0221925322
37OtherRVHRLLRKGNYAERV
HHHHHHHCCCHHHHC
52.0227105115
40PhosphorylationRLLRKGNYAERVGAG
HHHHCCCHHHHCCCC
20.6428152594
58PhosphorylationYLAAVLEYLTAEILE
HHHHHHHHHHHHHHH
12.75-
75OtherGNAARDNKKTRIIPR
CHHHHCCCCCCEEHH
60.8724681537
76OtherNAARDNKKTRIIPRH
HHHHCCCCCCEEHHH
49.6524681537
89MethylationRHLQLAVRNDEELNK
HHHHHHHCCHHHHHH
39.0024391501
96GlutarylationRNDEELNKLLGGVTI
CCHHHHHHHHCCEEE
58.6831542297
96UbiquitinationRNDEELNKLLGGVTI
CCHHHHHHHHCCEEE
58.6822817900
96SuccinylationRNDEELNKLLGGVTI
CCHHHHHHHHCCEEE
58.6822389435
96OtherRNDEELNKLLGGVTI
CCHHHHHHHHCCEEE
58.6827105115
102PhosphorylationNKLLGGVTIAQGGVL
HHHHCCEEEECCCCC
17.5520703100
105MethylationLGGVTIAQGGVLPNI
HCCEEEECCCCCCCE
45.3724352239
119GlutarylationIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.7631542297
119AcetylationIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.7622650731
119CrotonylationIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.7621925322
119OtherIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.7627105115
119N6-crotonyl-L-lysineIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.76-
119NeddylationIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.7632015554
119SumoylationIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.76-
119UbiquitinationIQAVLLPKKTESHKP
EEEEECCCCCCCCCC
72.7625015289
120CrotonylationQAVLLPKKTESHKPG
EEEECCCCCCCCCCC
56.4321925322
120UbiquitinationQAVLLPKKTESHKPG
EEEECCCCCCCCCCC
56.4323000965
120MethylationQAVLLPKKTESHKPG
EEEECCCCCCCCCCC
56.43-
120GlutarylationQAVLLPKKTESHKPG
EEEECCCCCCCCCCC
56.4331542297
120"N6,N6-dimethyllysine"QAVLLPKKTESHKPG
EEEECCCCCCCCCCC
56.43-
120AcetylationQAVLLPKKTESHKPG
EEEECCCCCCCCCCC
56.4330589205
121PhosphorylationAVLLPKKTESHKPGK
EEECCCCCCCCCCCC
49.1725470042
123PhosphorylationLLPKKTESHKPGKNK
ECCCCCCCCCCCCCC
41.8830576142
125UbiquitinationPKKTESHKPGKNK--
CCCCCCCCCCCCC--
65.8223000965
128UbiquitinationTESHKPGKNK-----
CCCCCCCCCC-----
70.8221906983
128"N6,N6-dimethyllysine"TESHKPGKNK-----
CCCCCCCCCC-----
70.82-
128MethylationTESHKPGKNK-----
CCCCCCCCCC-----
70.82-
130UbiquitinationSHKPGKNK-------
CCCCCCCC-------
66.26-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
2SPhosphorylationKinaseRPS6KA5O75582
Uniprot
121TPhosphorylationKinaseDCAF1Q9Y4B6
Uniprot
-KUbiquitinationE3 ubiquitin ligaseRNF8O76064
PMID:22199232
-KUbiquitinationE3 ubiquitin ligaseHUWE1Q7Z6Z7
PMID:22199232
-KUbiquitinationE3 ubiquitin ligaseBMI1P35226
PMID:16359901
-KUbiquitinationE3 ubiquitin ligaseBMI1#RNF2P35226#Q99496
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
2SAcetylation

15010469
2SPhosphorylation

15010469
2SPhosphorylation

15010469
2SPhosphorylation

15010469
4RMethylation

15823041
14Kubiquitylation

22980979
14Kubiquitylation

22980979
16Kubiquitylation

22980979
16Kubiquitylation

22980979
27KMethylation

15386022
27Kubiquitylation

15386022
63Kubiquitylation

15386022
105QMethylation

24352239
120Kubiquitylation

15386022
120Kubiquitylation

15386022
121TPhosphorylation

15078818

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H2A2B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H2A2B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Deimination of histone H2A and H4 at arginine 3 in HL-60granulocytes.";
Hagiwara T., Hidaka Y., Yamada M.;
Biochemistry 44:5827-5834(2005).
Cited for: ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Phosphorylation of histone H2A inhibits transcription on chromatintemplates.";
Zhang Y., Griffin K., Mondal N., Parvin J.D.;
J. Biol. Chem. 279:21866-21872(2004).
Cited for: PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
Ubiquitylation
ReferencePubMed
"DNA damage triggers nucleotide excision repair-dependentmonoubiquitylation of histone H2A.";
Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M.,de Waard H., Wu J., Yuan L., Citterio E., Houtsmuller A.B.,Neefjes J., Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
Genes Dev. 20:1343-1352(2006).
Cited for: UBIQUITINATION AT LYS-120.
"Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox genesilencing.";
Cao R., Tsukada Y., Zhang Y.;
Mol. Cell 20:845-854(2005).
Cited for: UBIQUITINATION AT LYS-120.
"Role of histone H2A ubiquitination in Polycomb silencing.";
Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P.,Jones R.S., Zhang Y.;
Nature 431:873-878(2004).
Cited for: UBIQUITINATION AT LYS-120.

TOP